These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 7588168)

  • 21. Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study.
    Majer M; Welberg LA; Capuron L; Miller AH; Pagnoni G; Reeves WC
    Psychosom Med; 2008 Sep; 70(7):829-36. PubMed ID: 18606722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention and executive functions in remitted major depression patients.
    Paelecke-Habermann Y; Pohl J; Leplow B
    J Affect Disord; 2005 Dec; 89(1-3):125-35. PubMed ID: 16324752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the HIV Dementia Scale in an elderly cohort of patients with subcortical cognitive impairment caused by subcortical ischaemic vascular disease or a normal pressure hydrocephalus.
    van Harten B; Courant MN; Scheltens P; Weinstein HC
    Dement Geriatr Cogn Disord; 2004; 18(1):109-14. PubMed ID: 15087586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
    Lutz MT; Helmstaedter C
    Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment(*).
    Koski L; Brouillette MJ; Lalonde R; Hello B; Wong E; Tsuchida A; Fellows L
    HIV Med; 2011 Sep; 12(8):472-80. PubMed ID: 21395965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. I. Neuropsychological performance and neurological status at baseline and at 12-month follow-up.
    Burgess AP; Riccio M; Jadresic D; Pugh K; Catalan J; Hawkins DA; Baldeweg T; Lovett E; Gruzelier J; Thompson C
    Psychol Med; 1994 Nov; 24(4):885-9. PubMed ID: 7892356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection.
    Janssen RS; Saykin AJ; Cannon L; Campbell J; Pinsky PF; Hessol NA; O'Malley PM; Lifson AR; Doll LS; Rutherford GW
    Ann Neurol; 1989 Nov; 26(5):592-600. PubMed ID: 2817835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitivity and specificity of a neuropsychological instrument in the evaluation of schizophrenia subtypes: a study with a Spanish speaking population].
    Hilda Picasso HL; Ostrosky F; Nicolini H
    Actas Esp Psiquiatr; 2005; 33(2):87-95. PubMed ID: 15768315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of the HIV dementia scale in assessing risk for significant HIV-related cognitive-motor deficits in a high-risk urban adult sample.
    Richardson MA; Morgan EE; Vielhauer MJ; Cuevas CA; Buondonno LM; Keane TM
    AIDS Care; 2005 Nov; 17(8):1013-21. PubMed ID: 16176897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. Multicenter AIDS Cohort Study (MACS).
    van Gorp WG; Satz P; Hinkin C; Selnes O; Miller EN; McArthur J; Cohen B; Paz D
    J Clin Exp Neuropsychol; 1991 Sep; 13(5):812-9. PubMed ID: 1955533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nature and determinants of neuropsychological functioning in late-life depression.
    Butters MA; Whyte EM; Nebes RD; Begley AE; Dew MA; Mulsant BH; Zmuda MD; Bhalla R; Meltzer CC; Pollock BG; Reynolds CF; Becker JT
    Arch Gen Psychiatry; 2004 Jun; 61(6):587-95. PubMed ID: 15184238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory.
    Falconer DW; Cleland J; Fielding S; Reid IC
    Psychol Med; 2010 Jun; 40(6):1017-25. PubMed ID: 19775495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HUMANS: An English and Spanish neuropsychological test battery for assessing HIV-1-infected individuals--initial report.
    Wilkie FL; Goodkin K; Ardila A; Concha M; Lee D; Lecusay R; Suarez P; Van Zuilen MH; Molina R; O'Mellan S
    Appl Neuropsychol; 2004; 11(3):121-33. PubMed ID: 15590347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment and antiretroviral treatment in a Peruvian population of patients with human immunodeficiency virus.
    Guevara-Silva EA
    Neurologia; 2014 May; 29(4):224-9. PubMed ID: 23972623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery.
    Maruff P; Currie J; Malone V; McArthur-Jackson C; Mulhall B; Benson E
    Arch Neurol; 1994 Jul; 51(7):689-95. PubMed ID: 8018042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of self-reported cognitive and motor dysfunction in HIV-positive patients.
    Wilkins JW; Robertson KR; Snyder CR; Robertson WK; van der Horst C; Hall CD
    Am J Psychiatry; 1991 May; 148(5):641-3. PubMed ID: 2018167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant.
    Mooney S; Hasssanein TI; Hilsabeck RC; Ziegler EA; Carlson M; Maron LM; Perry W;
    Arch Clin Neuropsychol; 2007 Feb; 22(2):175-86. PubMed ID: 17280813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Normalisation and validation of the Brief Neuropsychological Battery as the reference neuropsychological test in multiple sclerosis].
    Duque P; Ibanez J; Del Barco A; Sepulcre J; de Ramon E; Fernandez-Fernandez O;
    Rev Neurol; 2012 Mar; 54(5):263-70. PubMed ID: 22362474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.